Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $4.76B | $4.92B | -3.33% |
Cost of Revenue | $1.09B | $1.26B | -13.33% |
Net Income | $977M | $979.5M | -0.26% |
EPS (Basic) | $6.72 | $6.78 | -0.88% |
EPS (Diluted) | $6.70 | $6.74 | -0.59% |
SG&A Expense | $1.14B | $1.15B | -1.54% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $26.8B | $25.16B | +6.55% |
Current Assets | $7.11B | $10.43B | -31.86% |
Total Liabilities | $10.91B | $10.7B | +2.04% |
Current Liabilities | $3.11B | $3.19B | -2.46% |
Long-Term Debt | $6.29B | $6.28B | +0.12% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $1.18B | $942.3M | +25.12% |
Investing Cash Flow | $400.5M | $-1.71B | +123.47% |
Financing Cash Flow | $-684.8M | $-53.2M | -1187.22% |
D&A | $306.4M | $229.7M | +33.39% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Net Margin | 20.5% | — | — |
ROA | 3.6% | — | — |
Current Ratio | $2.287 | — | — |
Other companies in Biotechnology